Protective Action of Nitrone-Based Free Radical Traps against Oxidative Damage to the Central Nervous System

Advances in Pharmacology

Volumn 38, Issue C, 1996, Pages 361-378

  Floyd, Robert A ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000879568     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60991-6     Document Type: Article

References (71)

1. Arroyo P.L., Hatch-Pigott V., Mower H.F., and Cooney R.V. Mutagenicity of nitric oxide and its inhibition by antioxidants. Mutat. Res 281 (1992) 193-202
2. Buettner G.R., Scott B.D., Kerber R.E., and Mugge A. Free radicals from plastic syringes. Free Rad. Biol. Med. 11 (1991) 69-70
3. Cao W., Carney J.M., Duchon A., Floyd R.A., and Chevion M. Oxygen free radical involvement in ischemia and reperfusion injury to brain. Neurosci. Lett. 88 (1988) 233-238
4. Cao X., and Phillis J.W. α-Phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res. 644 (1994) 267-272
5. Carney J.M., Starke-Reed P.E., Oliver C.N., Landrum R.W., Chen M.S., Wu J.F., and Floyd R.A. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spacial memory by chronic administration of the spin-trapping compound N-tert-butyl-a-phenylnitrone. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 3633-3636
6. Carney J.M., Tatsuno T., and Floyd R.A. The role of oxygen radicals in ischemic brain damage: Free radical production, protein oxidation and tissue dysfunction. In: Krieglstein J., and Oberpichler-Schwenk H. (Eds). "Pharmacology of Cerebral Ischemia" (1992), Wissenschaftliche Verlagsgesellshchaft, Stuttgart 321-331
7. Chance B., Sies H., and Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59 (1979) 527-605
8. Chen G., Bray T.M., Janzen E.G., and Mccay P.B. Excretion, metabolism and tissue distribution of a spin trapping agent, α-phenyl-N-tert-butyl-nitrone (PBN) in rats. Free Rad. Res. Commun. 9 (1990) 317-323
9. Chen G., Bray T.M., Janzen E.G., and Mccay P.B. The role of mixed function oxidase (MFO) in the metabolism of the spin trapping agent α-phenyl-N-tert-butyyl-nitrone [PBN) in rats. Free Rad. Res. Commun. 14 (1991) 9-16
10. Cheng H.-Y., Liu T., Feuerstein G., and Barone F.C. Distribution of spin-trapping compounds in rat blood and brain: In vivo microdialysis determination. Free Rad. Biol. Med. 14 (1993) 243-250
11. Clough-Helfman C., and Phillis J.W. The free radical trapping agent N-tert-butyl-a-phenylnitrone (PBN) attenuates cerebral ischaemic injury in gerbils. Free Rad. Res. Commun. 15 (1991) 177-186
12. Dawson V.L., Dawson T.M., Bartley D.A., Uhl G.R., and Snyder S.H. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13 (1993) 2651-2661
13. Daynes R.A., Araneo B.A., Ershler W.B., Maloney C., Li G.-Z., and Ryu S.-Y. Altered regulation of IL-6 production with normal aging. J. Immunol. 150 (1993) 5219-5230
14. Drapier J.-C., and Hibbs Jr. J.B. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. J. Clin. Invest. 78 (1986) 790-797
15. Drapier J.-C., and Hibbs Jr. J.B. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J. Immunol. 140 (1988) 2829-2838
16. Drapier J.-C., Pellat C., and Henry Y. Generation of EPR-detectable nitrosyl-iron complexes in tumor target cells cocultured with activated macrophages. J. Biol. Chem. 266 (1991) 10162-10167
17. Edamatsu R., Mori A., and Packer L. The spin-trap N-tert-a-phenyl-butylnitrone prolongs the life span of the senescence accelerated mouse. Biochem. Biophys. Res. Commun. 211 (1995) 847-849
18. Ershler W.B. Interleukin-6: A cytokine for gerontologists. J. Am. Geriatr. Soc. 41 (1993) 176-181
19. Ershler W.B., Sun W.H., Binkley N., Gravenstein S., Volk M.J., Kamoske G., Klopp R.G., Roecker E.B., Daynes R.A., and Weindruch R. Interleukin-6 and aging: Blood levels and mononuclear cell production increase with advancing aging and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res. 12 (1993) 225-230
20. Ershler W.B., Sun W.R., and Binkley N. The role of interleukin-6 in certain age-related diseases. Drugs Aging 5 (1994) 358-365
21. Floyd R.A. Hydroxyl free-radical spin-adduct in rat brain synaptosomes: Observations on the reduction of the nitroxide. Biochim. Biophys. Acta 756 (1983) 204-216
22. Floyd R.A. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J. 4 (1990) 2587-2597
23. Floyd R.A. Measurement of oxidative stress in vivo. In: Davies K.J.A., and Ursini F. (Eds). "The Oxygen Paradox" (1995), CLEUP University Press, Italy 89-103
24. Floyd R.A. Mitochondrial damage in neurodegenerative disease. In: Packer L., Hiramatsu M., and Yoshikawa T. (Eds). "Free Radicals in Brain Physiology and Disorders" (1996), Academic Press, Orlando in press.
25. Floyd R.A., and Carney J.M. Age influence on oxidative events during brain ischemia/reperfusion. Arch. Gerontol. Geriatr. 12 (1991) 155-177
26. Floyd R.A., and Carney J.M. Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann. Neurol. 32 (1992) S22-S27
27. Floyd R.A., and Carney J.M. Nitrone radicals traps (NRTs) protect in experimental neurodegenerative diseases. In: Chapman C.A., Olanow C.W., Jenner P., and Youssim M. (Eds). "Neuroprotective Approaches to the Treatment of Parkinson's Disease and Other Neurodegenerative Disorders" (1995), Academic Press, London 69-90
28. Floyd R.A., Liu G.-J., and Wong P.K. Nitrone radical traps as protectors of oxidative damage in central nervous system. In: Cadenas E., and Packer L. (Eds). "Handbook of Synthetic Antioxidants" (1996), Dekker, New York in press.
29. Folbergrova J., Zhao Q., Katsura K.-I., and Siesjo B.K. N-tert-butyl-α-phenylnitrone improves recovery of brain energy state in rats following transient focal ischemia. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 5057-5061
30. Funahashi T., Floyd R.A., and Carney J.M. Age effect on brain pH during ischemia/reperfusion and pH influence on peroxidation. Neurobiol. Aging 15 (1994) 161-167
31. Granger D.L., and Lehninger A.L. Sites of inhibition of mitochondrial electron transport in macrophage-injured neoplastic cells. J. Cell Biol. 95 (1982) 527-535
32. Granger D.L., Taintor R.R., Cook J.L., and Hibbs Jr. J.B. Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration. J. Clin. Invest. 65 (1980) 357-370
33. Griffin W.S.T., Stanley L.C., Ling C., White L., Macleod V., Perrot L.J., White III C.L., and Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 7611-7615
34. Hamburger S.A., and Mccay P.B. Endotoxin-induced mortality in rats is reduced by nitrones. Circ. Shock 29 (1989) 329-334
35. Hess D.T., Patterson S.I., Smith D.S., and Skene J.H.P. Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature 366 (1993) 562-565
36. Hibbs Jr. J.B., Taintor R.R., Vavrin Z., and Rachlin E.M. Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157 (1988) 87-94
37. Iadecola C., Zhang F., and Xu X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am. J. Physiol. 268 (1995) R286-R292
38. Iadecola C., Zhang F., Xu S., Casey R., and Ross M.E. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J. Cereb. Blood Flow Metab. 15 (1996) 378-384
39. Janzen E.G. Spin trapping. Acc. Chem. Res. 4 (1971) 31-40
40. Janzen E.G., and Blackburn B.J. Detection and identification of short-lived free radicals by electron spin resonance trapping techniques (spin trapping): Photolysis of organolead, -tin, and mercury compounds. J. Am. Chem. Soc. 91 (1969) 4481-4490
41. Janzen E.G., West M.S., and Poyer J.L. Comparison of antioxidant activity of PBN with hindered phenols in initiated rat liver microsomal lipid peroxidation. In: Asada K., and Yoshikawa T. (Eds). "Frontiers of Reactive Oxygen Species in Biology and Medicine" (1994), Elsevier Science, Amsterdam 431-434
42. ++-dithiocarbamate spin trap. Free Rad. Res. Commun. 23 (1995) 287-295
43. Kurose I., Miura S., Fukumura D., Yonei Y.I., Saito H., Tada S., Suematsu M., and Tsuchiya M. Nitric oxide mediates Kupffer cell-induced reduction of mitochondrial energization in hepatoma cells: A comparison with oxidative burst. Cancer Res. 53 (1993) 2676-2682
44. Lancaster Jr. J.R., and Hibbs Jr. J.B. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 1223-1227
45. Lepoivre M., Flaman J.-M., and Henry Y. Early loss of the tyrosyl radical in ribonucle-otide reductase of adenocarcinoma cells producing nitric oxide. J. Biol. Chem. 267 (1992) 22994-23000
46. Mckechnie K., Furman B.L., and Parratt J.R. Modification by oxygen free radical scavengers of the metabolic and cardiovascular effects of endotoxin infusion in conscious rats. Circ. Shock 19 (1986) 429-439
47. Merrill J.E. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: Normal and pathological. Dev. Neurosci. 14 (1992) 1-10
48. Merrill J.E., and Jonakait G.M. Interactions of the nervous and immune systems in development, normal brain homeostasis, and disease. FASEB J. 9 (1995) 611-618
49. Meyer M., Schreck R., and Baeuerle P.A. H2O2 and antioxidants have opposite effects on activation of NF-KB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12 (1993) 2005-2015
50. Mitrovic B., Ignarro L.J., Montestruque S., Small A., and Merrill J.E. Nitric oxide as a potential pathological mechanism in demyelination: Its differential effects on primary glial cells in vitro. Neuroscience 61 (1994) 575-585
51. Miyajima T., and Kotake Y. Spin trapping agent, phenyl N-tert-butyl nitrone, inhibits induction of nitric oxide synthase in endotoxin-induced shock in mice. Biochem. Biophys. Res. Commun. 215 (1995) 114-121
52. Novelli G.P., Angiolini P., Consales G., Lippi R., and Tani R. Anti-shock action of phenyl-t-butyl-nitrone, a spin trapper. In: Novelli G.P., and Ursini F. (Eds). "Oxygen Free Radicals in Shock" (1986), Karger, Basel Florence 119-124
53. Novelli G.P., Anglolini P., and Tani R. The spin trap phenyl butyl nitrone prevents lethal shock in the rat. In: Poll G., Cheeseman K.H., Dianzani M.U., and Slater T.F. (Eds). "Free Radicals in Liver Injury" (1986), IRL Press Limited, Oxford 225-228
54. Novelli G.P., Angiolini P., Tani R., Consales G., and Bordi L. Phenyl-T-butyl-nitrone is active against traumatic shock in rats. Free Rad. Res. Commun. 1 (1985) 321-327
55. Oliver C.N., Starke-Reed P.E., Stadtman E.R., Liu G.J., Carney J.M., and Floyd R.A. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemiaheperfusion-induced injury to gerbil brain. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 5144-5147
56. Phillis J.W., and Clough-Helfman C. Protection from cerebral ischemic injury in gerbils with the spin trap agent N-tert-butyl-α-phenylnitrone (PBN). Neurosci. Lett. 116 (1990) 315-319
57. Phillis J.W., and Clough-Helfman C. Free radicals and ischaemic brain injury: Protection by the spin trap agent PBN. Med. Sci. Res. 18 (1990) 403-404
58. Pogrebniak H.W., Merino M.J., Hahn S.M., Mitchell J.B., and Pass H.I. Spin trap salvage from endotoxemia: The role of cytokine down-regulation. Surgery 112 (1992) 130-139
59. Rothwell N.J., and Relton J.K. Involvement of cytokines in acute neurodegeneration in the CNS. Neurosci. Biobehav. Rev. 17 (1993) 217-227
60. Schulz J.B., Henshaw D.R., Siwek D., Jenkins B.G., Ferrante R.J., Cipolloni P.B., Kowall N.W., Rosen B.R., and Beal M.F. Involvement of free radicals in excitotoxicity in vivo. J. Neurochem. 64 (1995) 2239-2247
61. Sen S., Goldman H., Morehead M., Murphy S., and Phillis J.W. α-Phenyl-tert-butyl-nitrone inhibits free radical release in brain concussion. Free Rad. Biol. Med. 16 (1994) 685-691
62. Stadler J., Billiar T.R., Curran R.D., Stuehr D.J., Ochoa J.B., and Simmons L. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am. J. Physiol. 260 (1992) C910-C916
63. Sun W.H., Binkley N., Bidwell D.W., and Ershler W.B. The influence of recombinant human interleukin-6 on blood and immune parameters in middle-aged and old Rhesus monkeys. Lymphokine Cytokine Res. 12 (1993) 449-455
64. Takehara Y., Kanno T., Yoshioka T., Inoue M., and Utsumi K. Oxygen-dependent regulation of mitochondrial energy metabolism by nitric oxide. Arch. Biochem. Biophys. 323 (1995) 27-32
65. 2+ injection. J. Neurochem. 42 (1984) 976-980
66. Troncoso J.C., and Costello A.C. Metal-catalyzed oxidation of bovine neurofilaments in vitro. Free Rad. Biol. Med. 18 (1995) 891-899
67. Willmore L.J., Sypert G.W., Munson J.B., and Hurd R.W. Chronic focal epilepti-form discharges induced by injection of iron into rat and cat cortex. Science 200 (1978) 1501-1503
68. Yue T.-L., Gu J.-L., Lysko P.G., Cheng H.-Y., Barone F.C., and Feuerstein G. Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global brain ischemia and in cultured rat cerebellar neurons. Brain Res. 574 (1992) 193-197
69. Zaleska M.M., Nagy K., and Floyd R.A. Iron-induced lipid peroxidation and inhibition of dopamine synthesis in striatum synaptosomes. Neurochem. Res. 14 (1989) 597-605
70. Zhang J., Dawson V.L., Dawson T.M., and Snyder S.H. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263 (1994) 687-689
71. Zhao Q., Pahlmark K., Smith M.-I., and Siesjo B.K. Delayed treatment with the spin trap α-phenyl-N-tert-butyl nitrone (PBN) reduces infarct size following transient middle cerebral artery occlusion in rats. Acta Physiol. Scand. 152 (1994) 349-350